Please Feel Free To Contact Us
In Iowa
800-382-0707
In Illinois
877-788-4590
|
M.D., F.A.C.C., F.A.C.P., F.C.C.P., F.S.C.A.I.
Dr. Shammas received his combined Master of Science-Doctor of Medicine (MS-MD) degrees at the American University of Beirut, Lebanon. He completed his Internal Medicine Residency at the University of Iowa Hospitals and Clinics and his Cardiology Fellowship at the University of Rochester Medical Center, Rochester, NY in 1994. He returned to the University of Iowa, Division of Cardiology where he was a Fellow Associate in Interventional Cardiology.
Dr. Shammas has been heavily involved in the research and development of new techniques and procedures and has gained numerous awards and recognition for such. Dr Shammas is board certified in Cardiovascular Disease and Interventional Cardiology. He is also a fellow of the American College of Cardiology, American College of Physicians and the Society of Cardiac Angiography.
Dr. Shammas has published over 100 manuscripts, abstracts and book chapters and presented at national and international meetings. He has served as a reviewer and on the editorial board of several peer-reviewed journals. He has participated in over 60 multicenter clinical trials and, in 1997, established the coronary and peripheral vascular research program at the Genesis Medical Center. Dr. Shammas has won several research and teaching awards including the Preceptor Teacher of the Year Award (2002) by the family practice residents at the Genesis Family Residency Training program. Dr. Shammas is the founder and president of the Midwest Cardiovascular Research Foundation.
Dr. Shammas is licensed in both Iowa and Illinois and is available for outpatient consultations and follow up visits at the Davenport Rusholme Street and Muscatine locations. He has staff privileges at Genesis Medical Centers and Trinity Medical Centers
Shammas NW, Coiner D, Shammas GA, Christensen L, Dippel EJ, Jerin M. Distal Embolic Event Protection Using Excimer Laser Ablation in Peripheral Vascular Interventions: Results of the DEEP EMBOLI Registry. J Endovasc Ther. 2009;16:197-202.
Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, van 't Hof A, Berdan LG, Lee KL, Strony JT, Hildemann S, Veltri E, Van de Werf F, Braunwald E, Harrington RA, Califf RM, Newby LK; EARLY ACS Investigators (Shammas N listed as one of the subinvestigators). Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med. 2009;360:2176-90
Shammas NW, Shammas GA, Dippel EJ, Jerin M. Intraprocedural Outcomes Following distal Lower Extremity Embolization in Patients Undergoing Peripheral Percutaneous Interventions. Vascular Disease Management, 2009; 6(3):1-5
Shammas NW, Dippel EJ, Shammas GA, Farland L, Brosius S, Jerin M, Avila A, Gehbauer L, Winter M, Stoakes P, Byrd J, Sharis P, Robken J. Long Term Outcomes with Bifurcating Coronary Lesions Stenting using the Paclitaxel Drug-Eluting Stent: a Single Center Experience. International Journal of Angiology, 2008;17 (2): 88-92
Shammas NW, Dippel EJ, Shammas G, Gayton L, Coiner D, Jerin M. Dethrombosis of the Lower Extremity Arteries Using the Power-Pulse Spray Technique in Patients with Recent Onset Thrombotic Occlusions: Results of the DETHROMBOSIS Registry. J Endovas Ther, 2008; 15(5):570-579
MEND-CABG II Investigators, Alexander JH, Emery RW Jr, Carrier M, Ellis SJ, Mehta RH, Hasselblad V, Menasche P, Khalil A, Cote R, Bennett-Guerrero E, Mack MJ, Schuler G, Harrington RA, Tardif JC. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial. JAMA. 2008 Apr 16;299(15):1777-87. Epub 2008 Apr 1. (Dr Shammas is listed as one of the principal investigator)
ADVANCE MPI investigators. Iskandrian et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial. J Nuclear Cardiology 2007;14:645-658 (Dr Shammas is listed as one of the principal investigator)
Shammas NW, Dippel EJ, Coiner D, Shammas GA, Jerin M, Kumar A. PReventing LOwer ExTremity Distal Embolization Using EmboliC FilTer Protection: Results of the PROTECT Registry. J Endovas Ther, 2008; 15:270-276
Shammas NW, Dippel EJ, Shammas GA, Kumar A, Jerin M, Kennedy L. Utilization of GpIIb/IIIa inhibitors in Peripheral Percutaneous Interventions: Current Applications and in-Hospital Outcomes in a Tertiary Referral Center. J Invasive Cardiology, 2008; 20:266-269
Shammas NW, Dippel EJ, Jerin M, Toth PP, Kapalis M, Reddy M, Harb H. Elevated Levels of Homocysteine Predict Cardiovascular Death, Non Fatal Myocardial Infarction and Symptomatic Bypass Graft Disease at 2-Year Follow-Up Following Coronary Artery Bypass Surgery. Preventive Cardiology, 2008; 11: 95-99
Triton-TIMI 38 investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. (Shammas NW listed as one of the principal investigators in the publication appendix online), N Engl J Med 2007;;357:2001-15
Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Shammas GA, Sharis P. Interatrial septal defect closure for prevention of cerebrovascular accidents:Exploring the Role of Various Anticoagulants. J Invasive Cardiol, 2007;19(7):309-12
Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Shammas GA, Sharis P. Interatrial septal defect closure for prevention of cerebrovascular accidents: impact on recurrence and frequency of migraine headaches. J Invasive Cardiol. 2007;19:257-60
Robken J, Shammas NW. Treatment of totally occluded superior mesenteric artery by retrograde crossing via collaterals from the Celiac artery. J Endovascular Therapy 2007;14(5):745-7
Shammas NW. Trifurcating Coronary artery disease: a proposed classification and treatment methodology. J Invasive Cardiol 2007;19:32-35
Shammas NW, Dippel EJ, Avila A, Gehbauer L, Farland L, Brosius S, Jerin M, Winter M, Stoakes P, Byrd J, Majetic L, Shammas G, Sharis P, Robken J. Long-term outcomes in left main trifurcation coronary artery disease with the paclitaxel-eluting stent. J Invasive Cardiol, 2007;19:77-82
Shammas NW, Dippel EJ, Amidon C, Patel P, Ancheta G, Ratnakar S, Harb H. In-hospital complications in treating chronic limb ischemia: the feasibility of alternative anticoagulation therapy to unfractionated heparin. Vascular Disease Management 2006;3:328-330
Shammas NW, Kapalis MJ., Kirchner HL, Lemke JH, Hauber W, Dippel EJ. Defect Size on Sestamibi Stress Testing Does Not Predict High Sensitive C - Reactive Protein in Patients with Coronary Artery Disease. International Journal of Angiology, 2006;15:120-124
Charisma Trial Investigators: Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. (Shammas NW listed as one of the principal investigators in the publication appendix), N Engl J Med 2006;354 (online version publication pre print)
Dippel EJ, Shammas NW, Takes VS, Coyne LE, Lemke JH. Twelve-month results of percutaneous endovascular reconstruction for chronically occluded superficial arteries: a quality of life assessment. J Invasive Cardiol, 2006;18(6):316-321
Shammas NW, Lemke JH, Deckert J, Toth PP, Mckinney D, Dippel EJ. Gender differences in adhering to national guidelines in a community lipid clinic. Preventive Cardiology, 2006 Fall;9(4):215-8
Gibson CM, Kirtane AJ, Murphy SA, Rohrbeck S, Cohen M, Lins J, Kazziha S, Rokos I, Shammas NW, Palabrica TM, Fish P, McCabe CH, Braunwald E. Time to integral therapy in acute myocardial infarction (TITAN)-TIMI-34. Am Heart J. 2006;152(4):668-75
Patel P, Shammas NW, Kapalis MJ, Dippel EJ, Lemke J, Harb C. Routine visualization of the left internal mammary artery before bypass surgery: is it necessary? J Invasive Cardiology 2005;15:479-481
Al-Shaer MH, Shammas NW, Lemke JH, Kapalis MJ, Dippel EJ, Harb H, Reddy G, McKinney G, Mahadevia AK. CPAP does not reduce hs-CRP in patients with coronary artery disease and obstructive sleep apnea. International Journal of Angiology, 2005;14:129-132
Shammas NW, Allie D, Hall P, Safian R, Laird JR, Young JJ, Virmani A. Predictors of In-Hospital and 30-day Complications of Peripheral Vascular Interventions Using Bivalirudin as The Primary Anticoagulant: Results from the APPROVE Registry. J Invasive Cardiol 2005;17:356-359
Shammas NW, Dippel,EJ, Lemke JH, Robken J, Kirchner HL, Takes V, Kapalis MJ, Palabrica T. Eptifibatide in Peripheral Vascular Interventions: Results of the Integrillin Reduces Inflammation in Peripheral Vascular Interventions (INFLAME) trial. J Invasive Cardiol 2006;18:6-12
Shammas NW, Dippel EJ, Buttler KE. Endovascular Stent-Graft Repair of Renal Dissection With Expanding Intramural Hematoma Following Renal Artery Stenting. Vascular Disease Management March/April, pg 2-4, 2005 (commentary by Richard Heuser)
Allie D., Hall P., Shammas NW, Safian R., Laird JR, Young J., Virmani A.: The Angiomax Peripheral Procedure Registry of Vascular Events Trial (APPROVE); In-Hospital and 30 - Day Results. Journal of Invasive Cardiology 16:651 - 656, 2004
Harris M, Shammas NW, Jerin M: Elevated Levels of Low-density Lipoprotein Cholesterol, Homocysteine, and Lipoprotein (a) are Associated with the Occurrence of Symptomatic Bypass Graft Disease One Year following Coronary Artery Bypass Surgery. Preventive Cardiology 2004 Summer; 7(3):106-8
Shammas NW, Lemke JH, Harris M, McKinney D, Cummins K, Brookhart C, Loukinen S: Effect of Intravenous Diltiazem and Digoxin on Atrial Fibrillation After On-Pump Coronary Artery Bypass Surgery. International Journal of Angiology13:22-26, 2004
Shammas NW, Kapalis MJ, Dippel EJ, Jerin MJ, Lemke JH, Patel P, Harris M: Clinical and Angiographic Predictors of Restenosis Following Renal Artery Stenting. Journal of Invasive Cardiology16:10-13, 2004
Shammas NW, Dippel EJ, Fagan T, Hull M: Protruding Umbrella into the Left Atrium Associated with a Recurrence of a Stroke: A Rare Complication of the CardioSeal Occluder. Journal of Invasive Cardiology 16:76-77, 2004
Shammas NW. Optimal Strategy in Lower Extremity Peripheral Percutaneous Interventions: An Interventionalist's Perspective. Vascular Disease Management 2009;6:36-40
Shammas NW, Sica DA, Toth PP. A Guide to the Management of Blood Pressure in the Diabetic Hypertensive Patient. American Journal of Cardiovascular Drugs, 2009;9(3):149-162
Shammas NW. Restenosis in Lower Extremity Interventions: Current Status and Future Directions. J Endovasc Ther 2009, 16 (Suppl I): I170-182
Shammas NW. Embolization in lower extremity percutaneous interventions: recommendations and strategies for embolic filter protection use. Vascular Disease Management, January/February, 2008;5:22-26
Shammas NW. Peripheral Arterial Disease: book review. Vascular Disease Management, January/February, 2008;5:35-36
Shammas NW. Trifurcating coronary artery disease: expanding the frontier of interventional cardiology. Letter to the Editor. J Invasive Cardiol 2007;19(6):284
Sharis P, Shammas NW. Evidence-based treatment of unprotected left main disease: a critical review of the literature. Current Atherosclerosis Report 2007;9(5):397-400
Shammas NW. A guide to the management of blood pressure in the diabetic hypertensive patient. Am J Cardiovasc Drugs (submitted)
Shammas NW. Epidemiology, classification and modifiable risk factors of peripheral arterial disease. Vascular Health and Risk Management, 2007;3(2):229-234
Shammas NW. An overview of pharmacotherapy during percutaneous peripheral interventions of thrombotic lesions. Vascular Disease Management, March/April, 6C-12C, 2006
Shammas NW. Dethrombosis of the lower extremities: pharmacologic and mechanical techniques. Vascular Disease Management, May/June, 2006
Shammas NW. Current and future perspectives of endovascular therapy of peripheral vascular disease. International Review of Thrombosis, 2006;1(2):38-41
Shammas NW. Bivalirudin: a Review of Pharmacology and Clinical Applications. Cardiovascular Drug Reviews, 2005; 23 (4):345-360
Shammas NW. Current Clinical Applications of Bivalirudin: an Overview. Vascular Disease Management March/April 2006: 243-246
Shammas NW. In-stent restenosis in the renal arteries: the role of brachytherapy. Commentary to Vascular Disease Management January/February, page 184, 2006
Allie DE, Hall PA, Shammas NW, Safian R, Laird JR, Young JJ, Virmani A. Bivalirudin in peripheral vascular interventions. Results from the APPROVE trial and the emerging role of "endopharmacology" in treating PVD. Endovascular Today, May 2005, 27-32
Shammas NW. Achieving Optimal Platelet Inhibition During Percutaneous Coronary Interventions. Vascular Disease Management, May/June 2005, page 64-65
Shammas NW, Dippel EJ. Evidence-Based Management of Peripheral Vascular Disease. Current Atherosclerosis Reports,2005:7:358-363
Smith CH, Erwin NB, Deliargyris EN, : Tissue Shearing with distal translocation complicating Cutting Balloon Angioplasty During Treatment of In-stent restenosis. Journal of Invasive Cardiology, 17 (1): 40 - 41, 2005(Editorial Commentary by Shammas NW)
Shammas NW, Complications in Peripheral Vascular Interventions: Emerging Role of Direct Thrombin Inhibitors. Journal of Vascular Intervention Radiology, 16 (2):165-71, 2005
Abstracts
Shammas NW, Coiner D, Shammas G, Dippel E, Christensen L, Jerin M. Percutaneous Lower Extremity Arterial Interventions Using Balloon Angioplasty Versus Silverhawk Atherectomy: Results Of The SMARTHAWK Randomized Trial. Presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 32nd Annual Scientific Sessions in Las Vegas from May 6-9, 2009. Catheterization and Cardiovascular Interventions, 2009, 73 (7):S42 (Abstract C-4)
Shammas NW, Shammas G, Coiner D, Dippel E, Christensen L, Jerin M. Walking Impairment Questionnaire, Ankle-Brachial Index And Rutherford-Baker Class In Patients Undergoing Angioplasty Versus Silverhawk Atherectomy: Results From The SMARTHAWK Randomized Trial. Presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 32nd Annual Scientific Sessions in Las Vegas from May 6-9, 2009. Catheterization and Cardiovascular Interventions, 2009, 73 (7):S21 (AbstractA-32)
Shammas NW, Dippel EJ, Shammas GA, Jerin M, Bryan D, Rauba J. Does High Sensitivity C-Reactive Protein Predict Target Lesion Revascularization in Patients Undergoing Lower Extremity Percutaneous Interventions? Transcatheter Cardiovascular Therapeutics 2008, Washington DC, October 12-17. American Journal of Cardiology , 102 (8): 227i, TCT-603
Shammas NW, Shammas GA, Dippel EJ, Jerin M, Hahn A, Winter M. In-Hospital Complications and Long Term Safety of The Paclitaxel Drug Eluting Stent in Acute ST Elevation Myocardial Infarction: A Real World Experience From a High-Volume Medical Center. Presented at New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Shammas NW, Shammas GA, Dippel EJ, Jerin M. In hospital Outcomes of Patients Undergoing Peripheral Percutaneous Interventions with Subsequent Distal Lower Extremity Atheroembolization. New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Shammas NW, Dippel EJ, Shammas GA, Jerin M, Bryan D, Rauba J. Does High Sensitivity C-Reactive Protein Predict Target Lesion Revascularization in Patients Undergoing Lower Extremity Percutaneous Interventions? New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Sharis PJ, Voelliger CM; Ahuja A; Vigliotti D, Jerin M, Robken J, Shammas NW. Large Single Center Experience with Unprotected Left Main Coronary Artery Drug-Eluting Stenting in 289 Patients. New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Shammas NW, Shammas GA, Jerin M, Parikh A, Coin K, Dippel EJ, Robken J. Treatment of Left Main Trifurcation Coronary Artery Disease with the Paclitaxel-Eluting Stent: Long term Outcome from a Tertiary Medical Center. New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Shammas NW, Coiner D, Shammas GA, Dippel EJ, Christensen L. Distal Embolic Event Protection Using Excimer Laser Ablation in Peripheral Vascular Interventions: Preliminary Results of the DEEP EMBOLI Registry. New Cardiovascular Horizons 2008, September 10-13, New Orleans, Louisianna
Shammas NW, Dippel EJ, coiner D , Gayton L, Shammas GA. Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection: Results of the Pilot PROTECT Registry. Presented at ACC/SCAI i2, E. Poster, Chicago, IL, 2008. JACC, 51 (10), Supplement B, B76 (abstract # 2900-234)
Shammas NW, Dippel EJ, Gayton L, Coiner D, Shammas GA, Byrd J, Stoakes P. Prevalence of Thrombus in Patients with a Recent History of Claudication or Rest Limb Pain: An Intravascular Ultrasound Assessment. Presented at CRT 2008, February, Washington DC., CRT 2008, 9:page 116.
Shammas NW, Dippel EJ, coiner D, Stoakes P, Gayton L, Shammas GA. Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection: Results of the Pilot PROTECT Registry. Presented at CRT 2008, February, Washington DC. CRT 2008, 9:page 115.
Shammas NW, Dippel EJ, Coiner D, Gayton D, Shammas GA, Byrd J, Stoakes P. Safety and Effectiveness of the Power-Pulse Spray in Treating Patients with Recent Onset of Claudication and Limb Ischemia. Presented at CRT 2008, February, Washington DC. CRT 2008, 9:page 116.
Shammas NW, Dippel E, Shammas GA, Kumar A, Jerin M, Kennedy L. Utilization of GpIIb/IIIa inhibitors in Peripheral Percutaneous Interventions: Current Applications and in-Hospital Outcomes in a Tertiary Referral Center. Presented at CRT 2008, February, Washington DC.
Shammas NW, Dippel EJ, Sharis P, Robken J, Farland L, Brosius S, Jerin M, Avila A, Gehbauer L, Winter M, Shammas GA, Stoakes P, Byrd J, Kennedy L, Millette LA. Main Branch and Side Branch Stenting versus Provisional One Branch Stenting for Bifurcating Coronary Lesions using the Paclitaxel Drug-Eluting Stent: a single Center Experience with Intermediate term follow-up. Presented at CRT 2008, February, Washington DC. CRT 2008, 9:page 116.
Shammas NW, Coiner , Shammas GA, Dippel EJ. Reduced Stent Utilization with Silverhawk Atherectomy versus Balloon Angioplasty in Patients Undergoing Peripheral Vascular Interventions: a Randomized Trial. Presented at CRT 2008, February, Washington DC. CRT 2008, 9:page 115.
Shammas NW, Dippel EJ, Sharis P, Robken J, Farland L, Brosius S, Jerin M, Avila A, Gehbauer L, Winter M, Shammas GA, Stoakes P, Byrd J, Kennedy L, Millette LA. Long Term Outcomes with Bifurcating Coronary Lesions Stenting using the Paclitaxel Drug-Eluting Stent: a Single Center Experience. Presented at CRT 2008, February, Washington DC. CRT 2008, 9:page 115.
Shammas NW, Dippel EJ, Gayton L, Coiner D, Shammas GA, Byrd J, Stoakes P. Prevalence of thrombus in patients with a recent history of claudication or rest limb pain: an intravascular ultrasound assessment. Abstract #4. Presented at New Cardiovascular Horizons 2007, New Orleans, LA.
Shammas NW, Dippel EJ, Coiner D, Gayton D, Shammas GA, Byrd J, Stoakes P. Safety and Effectiveness of the Power-Pulse Spray in Treating Patients with Recent Onset of Claudication and Limb Ischemia. Abstract #10. Presented at New Cardiovascular Horizons 2007, New Orleans, LA.
Shammas NW, Dippel EJ, Sharis P, Robken J, Farland L, Brosius S, Jerin M, Avila A, Gehbauer L, Winter M, Shammas GA, Stoakes P, Byrd J, Kennedy L, Millette LA. Main Branch and Side Branch Stenting versus Provisional One Branch Stenting for Bifurcating Coronary Lesions using the Paclitaxel Drug-Eluting Stent: a Single Center Experience with Intermediate Term Follow-up. Abstract #14. Presented at New Cardiovascular Horizons 2007, New Orleans, LA.
Shammas NW, Dippel EJ, Sharis P, Robken J, Farland L, Brosius S, Jerin M, Avila A, Gehbauer L, Winter M, Shammas GA, Stoakes P, Byrd J, Kennedy L, Millette LA. Intermediate Term Outcomes with Bifurcating Coroanry Lesions Stenting using the Paclitaxel Drug-Eluting Stent: A single Center Experience. Abstract #16. Presented at New Cardiovascular Horizons 2007, New Orleans, LA
Shammas NW, Dippel EJ, Coiner D, Stoakes P, Gayton L, Shammas GA. Preventing Lower Extremity Distal Embolization Using Embolic Filter Protection: Preliminary Results of a Pilot Registry. Abstract #22. Presented at New Cardiovascular Horizons 2007, New Orleans, LA
Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Sharis P. Interatrial Septal Defect Closure For Cerebrovascular Accidents: Impact on Intensity and Frequency of Migraine Headaches. Presented at New Cardiovascular Horizons 2006, New Orleans, LA.
Shammas NW, Dippel EJ, Harb G, Egts S, Jerin M, Stoakes P, Byrd J, Sharis P. Interatrial Septal Defect Closure For Cerebrovascular Accidents: The Role of The Intraprocedural Use of Bivalirudin. Presented at New Cardiovascular Horizons 2006, New Orleans, LA.
Shammas NW, Dippel EJ, Wisdom A, Gehbauer L, Farland L, Brosius S, Jerin M, Winter M, Stoakes P, Byrd J, Majetic L, Sharis P, Robken J. Long Term Outcome in Treating Trifurcation Coronary Artery Disease with the Taxus Drug Eluting Stent. Presented at New Cardiovascular Horizons 2006, New Orleans, LA.
Shammas NW, Dippel EJ, Amidon C, Patel P, Ancheta G. In-hospital complications in treating chronic limb ischemia: a comparative analysis of anticoagulation regimens. Presented at Cardiovascular Revascularization Therapies, Washington DC, 2006
Shammas NW, Dippel EJ, Lemke JH, Kirchner HL,Robken J, Takes V. Is Thrombin Suppression Adequate With Low Dose Heparin (LDH) and Eptifibatide versus High Dose Heparin (HDH) in Patients Undergoing Peripheral Percutaneous Interventions (PPI)? Presented at Cardiovascular Revascularization Therapies, Washington DC, 2006 ("10 best abstract" award at the meeting)
Shammas NW, Allie D, Hall P, Young J, Laird J, Safian R, Virmani A. Predictors of In-Hospital and 30-day Complications of Peripheral Vascular Interventions Using Bivalirudin as the Primary Anticoagulant: Results from the Approve Registry. Presented at Cardiovascular Revascularization Therapy (CRT) 2005, March 28-31, Washington DC, 2005. Published in Cardiovascular Revascularization Medicine, 2005.
Laird JR, Allie D, Hall P, Shammas NW, Safian R, Young JL, Vermani A. Bivalirudin provides effective anticoagulation in patients undergoing percutaneous peripheral interventions. Presented at ISET 2005, January 16 - 20, Miami Beach, Florida
Books/Book Chapters
Shammas NW, Williams M, McGee C. Developing and Implementing an ST-segment Elevation Myocardial Infarction (STEMI) Alert System in a Tertiary Hospital: Impact on Door-to-Balloon Time and Hospital Outcomes. In Textbook of STEMI Interventions, Editor, Sameer Mehta, HMP communications, First Edition, 349-357, 2008.
Shammas NW. Peripheral Vascular Disease Section. In Evidence-Based Cardiology, by Sharis P, Cannon CP. Third Edition, Lippincott Williams & Wilkins, 2007
Shammas NW. Heart disease as we grow older. In Live Longer, Live Healthier. The Secrets for Graceful Aging, first edition, MCRF, USA, Pages 13-30, 2007
Shammas NW, Editor, Live Longer, Live Healthier. The Secrets for Graceful Aging, first edition, MCRF, USA, ISBN-13: 9780975538425, 2007
Shammas NW. Congestive Heart Failure: Epidemiology, Pathophysiology, and Current Therapies. In Comprehensive Management of High Risk Cardiovascular Patients. Edited by Gotto AM, Toth PP. pp 525-544, 2006
Toth PP, Shammas NW, Dippel EJ, Foreman B. Cardiovascular Medicine, in: Rakel Textbook of Family Medicine, Elsevier Science Health Science div, 2006
Shammas NW, Editor, Learn About Your Heart...Made Simple, second edition, HMP communications, USA, 2005
Shammas NW, Editor-in-Chief, In Learn About Your Heart Made Simple, first edition, MCRF, USA, ISBN 0-9755384-0-3, 2004
Shammas NW, Statistics about heart and blood vessel diseases in the United States. In Learn About Your Heart Made Simple, MCRF, USA, ISBN 0-9755384-0-3, 1 - 12, 2004
Shammas NW, Structure and Function of the Heart and Blood Vessels. In Learn About Your Heart Made Simple, MCRF, USA, ISBN 0-9755384-0-3, 13 - 22, 2004
Shammas NW, Diseases of the Blood Vessels of the Heart. In Learn About Your Heart Made Simple, MCRF, USA, ISBN 0-9755384-0-3, 23 - 40, 2004
Shammas NW, How much did you learn from this book? Take a simple test. In Learn About Your Heart Made Simple, MCRF, USA, ISBN 0-9755384-0-3, 238 - 244, 2004
Dippel EJ, Shammas NW, Coyne LE, Takes VS: Endovascular Reconstruction for Chronically Occluded Superficial Femoral Arteries: Improving Quality of Life with a Percutaneous Therapy for Surgical Disease. In Cardiovascular Interventions and Practice Guidelines 2004, Midwest Cardiovascular Research Foundation, USA, 2004
ISBN 0-9755384-1-1
| 
|